February 2020

U.S. FDA/EMA Regulatory Inspection and Enforcement Trends

In this article our expert Lynne Byers and Jenny Yu from Munich Re Group compare regulatory findings from the U.S. FDA and the EMA, specifically 483s and non-conformance reports. They provide insight into emerging trends from both agencies and highlight the important questions managers need to ask to stay in compliance.